Moloney Securities Asset Management, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Moloney Securities Asset Management, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$593,000
-1.2%
14,7500.0%0.10%
-7.3%
Q3 2021$600,000
-31.4%
14,750
-23.4%
0.11%
-31.4%
Q2 2021$874,000
+8.8%
19,2500.0%0.16%
+0.6%
Q1 2021$803,000
-2.3%
19,2500.0%0.16%
-13.2%
Q4 2020$822,000
+111.9%
19,250
+30.5%
0.18%
+78.4%
Q3 2020$388,00014,7500.10%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders